221 related articles for article (PubMed ID: 32921357)
1. Immune Therapy for Central Nervous System Metastasis.
McAvoy MB; Choi BD; Jones PS
Neurosurg Clin N Am; 2020 Oct; 31(4):627-639. PubMed ID: 32921357
[TBL] [Abstract][Full Text] [Related]
2. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Lauko A; Thapa B; Venur VA; Ahluwalia MS
Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
[TBL] [Abstract][Full Text] [Related]
3. Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune Oncology.
Brastianos P; Davies MA; Margolin K; Yu HA
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e59-e69. PubMed ID: 31099629
[TBL] [Abstract][Full Text] [Related]
4. Emerging Immunotherapies in the Treatment of Brain Metastases.
Nieblas-Bedolla E; Nayyar N; Singh M; Sullivan RJ; Brastianos PK
Oncologist; 2021 Mar; 26(3):231-241. PubMed ID: 33103803
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors for Brain Metastases.
Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
[TBL] [Abstract][Full Text] [Related]
6. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.
Ramakrishna R; Formenti S
World Neurosurg; 2019 Oct; 130():615-622. PubMed ID: 31581411
[TBL] [Abstract][Full Text] [Related]
7. Development of immunotherapy for brain metastasis (Review).
Ding R; Chen L; Su Z; Xiong T; Wen Q; Peng Q; Jiang F
Int J Oncol; 2020 Sep; 57(3):665-677. PubMed ID: 32705149
[TBL] [Abstract][Full Text] [Related]
8. The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.
Nejo T; Mende A; Okada H
Jpn J Clin Oncol; 2020 Oct; 50(11):1231-1245. PubMed ID: 32984905
[TBL] [Abstract][Full Text] [Related]
9. Expected Paradigm Shift in Brain Metastases Therapy-Immune Checkpoint Inhibitors.
Jindal V; Gupta S
Mol Neurobiol; 2018 Aug; 55(8):7072-7078. PubMed ID: 29383686
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
11. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
12. The biology and therapeutic management of melanoma brain metastases.
Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy targeting immune check-point(s) in brain metastases.
Di Giacomo AM; Valente M; Covre A; Danielli R; Maio M
Cytokine Growth Factor Rev; 2017 Aug; 36():33-38. PubMed ID: 28736183
[TBL] [Abstract][Full Text] [Related]
14. Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.
Lee HW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208157
[TBL] [Abstract][Full Text] [Related]
15. Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases.
ElJalby M; Pannullo SC; Schwartz TH; Parashar B; Wernicke AG
World Neurosurg; 2019 Jul; 127():397-404. PubMed ID: 31004856
[TBL] [Abstract][Full Text] [Related]
16. Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review.
Lin X; Lu T; Xie Z; Qin Y; Liu M; Xie X; Li S; Zhou C
Thorac Cancer; 2019 May; 10(5):1272-1275. PubMed ID: 30929314
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
18. Metastases to the central nervous system: Molecular basis and clinical considerations.
Wanleenuwat P; Iwanowski P
J Neurol Sci; 2020 May; 412():116755. PubMed ID: 32120132
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.
Berghoff AS; Venur VA; Preusser M; Ahluwalia MS
Am Soc Clin Oncol Educ Book; 2016; 35():e116-22. PubMed ID: 27249713
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy and radiation in glioblastoma.
Sahebjam S; Sharabi A; Lim M; Kesarwani P; Chinnaiyan P
J Neurooncol; 2017 Sep; 134(3):531-539. PubMed ID: 28567588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
